We provide you with 20 years of free, institutional-grade data for TCRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TCRX. Explore the full financial landscape of TCRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Tscan Therapeutics Inc(NASDAQ:TCRX) 
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Share this website to your friends
The information provided in this report about TCRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.